Ribotype stability of serial pulmonary isolates of Pseudomonas cepacia.

PubWeight™: 1.55‹?› | Rank: Top 4%

🔗 View Article (PMID 1711551)

Published in J Infect Dis on July 01, 1991

Authors

J J LiPuma1, M C Fisher, S E Dasen, J E Mortensen, T L Stull

Author Affiliations

1: Department of Pediatrics, Medical College of Pennsylvania, Philadelphia 19129.

Articles citing this

Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev (1996) 13.91

Molecular epidemiology of Pseudomonas cepacia determined by polymerase chain reaction ribotyping. J Clin Microbiol (1992) 3.13

Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting. J Clin Microbiol (1996) 2.95

Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. J Clin Microbiol (1994) 2.74

Discriminatory power of three DNA-based typing techniques for Pseudomonas aeruginosa. J Clin Microbiol (1995) 2.43

Use of ribotyping in epidemiological surveillance of nosocomial outbreaks. Clin Microbiol Rev (1994) 2.26

Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin Microbiol Rev (2011) 2.23

Arbitrarily primed polymerase chain reaction as a rapid method to differentiate crossed from independent Pseudomonas cepacia infections in cystic fibrosis patients. J Clin Microbiol (1993) 1.60

Ribotype analysis of Pseudomonas pseudomallei isolates. J Clin Microbiol (1993) 1.52

Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fibrosis. J Clin Microbiol (1993) 1.45

Genotypic analysis of Burkholderia cepacia isolates from 13 French cystic fibrosis centers. J Clin Microbiol (1997) 1.29

Ribotyping for differentiating Flavobacterium meningosepticum isolates from clinical and environmental sources. J Clin Microbiol (1994) 1.15

PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients. J Clin Microbiol (2001) 1.10

Distinguishing species of the Burkholderia cepacia complex and Burkholderia gladioli by automated ribotyping. J Clin Microbiol (2000) 1.07

Characterization of PCR-ribotyping for Burkholderia (Pseudomonas) cepacia. J Clin Microbiol (1994) 1.07

Articles by these authors

Phylogenetic species recognition and species concepts in fungi. Fungal Genet Biol (2000) 7.71

Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet (1990) 4.39

Characterization of non-beta-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob Agents Chemother (1984) 4.25

Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients. J Clin Microbiol (1999) 3.19

Molecular epidemiology of Pseudomonas cepacia determined by polymerase chain reaction ribotyping. J Clin Microbiol (1992) 3.13

Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers. J Pediatr (1988) 2.60

Detection of Pseudomonas (Burkholderia) cepacia using PCR. Pediatr Pulmonol (1995) 2.44

Failure to detect ampicillin-resistant, non-beta-lactamase-producing Haemophilus influenzae by standard disk susceptibility testing. Antimicrob Agents Chemother (1986) 2.38

Protein sources of heme for Haemophilus influenzae. Infect Immun (1987) 2.23

DNA polymorphisms among Escherichia coli isolated from bacteriuric women. J Infect Dis (1989) 2.02

Characterization of Haemophilus influenzae type b fimbriae. Infect Immun (1984) 2.00

Identification and detection of Stenotrophomonas maltophilia by rRNA-directed PCR. J Clin Microbiol (2000) 1.90

Problems with current recommendations for susceptibility testing of Haemophilus influenzae. Antimicrob Agents Chemother (1990) 1.84

A permeability barrier as a mechanism of chloramphenicol resistance in Haemophilus influenzae. Antimicrob Agents Chemother (1985) 1.84

Iron acquisition by Haemophilus influenzae. Infect Immun (1988) 1.82

Bacteriology of acute otitis media: a new perspective. J Pediatr (1992) 1.80

A universal approach to bacterial molecular epidemiology by polymerase chain reaction ribotyping. J Infect Dis (1995) 1.77

The Calyptogena magnifica chemoautotrophic symbiont genome. Science (2007) 1.73

Importance of culture in laboratory diagnosis of Bordetella pertussis infections. J Clin Microbiol (1984) 1.70

Comparative virulence of Haemophilus influenzae with a type b or type d capsule. Infect Immun (1981) 1.66

Species-specific PCR as a tool for the identification of Burkholderia gladioli. J Clin Microbiol (2000) 1.65

'Haptoglobin concentrations in preterm and term newborns'. J Perinatol (2011) 1.54

Cerebrospinal fluid analysis in systemically ill children without central nervous system disease. Pediatrics (1995) 1.51

Comparison of culture and PCR for detection of Burkholderia cepacia in sputum samples of patients with cystic fibrosis. J Clin Microbiol (1998) 1.50

In vitro activities and targets of three cephem antibiotics against Haemophilus influenzae. Antimicrob Agents Chemother (1989) 1.49

Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fibrosis. J Clin Microbiol (1993) 1.45

In vitro susceptibility testing of topical antimicrobial agents used in pediatric burn patients: comparison of two methods. J Burn Care Rehabil (1997) 1.45

Construction of antibiotic resistance cassettes with multiple paired restriction sites for insertional mutagenesis of Haemophilus influenzae. FEMS Microbiol Lett (1998) 1.42

Effect of multiple mutations in the hemoglobin- and hemoglobin-haptoglobin-binding proteins, HgpA, HgpB, and HgpC, of Haemophilus influenzae type b. Infect Immun (1999) 1.41

Using itraconazole to clear Batrachochytrium dendrobatidis infection, and subsequent depigmentation of Alytes muletensis tadpoles. Dis Aquat Organ (2009) 1.38

Inapparent transmission of Pseudomonas (Burkholderia) cepacia among patients with cystic fibrosis. Pediatr Infect Dis J (1994) 1.34

Pseudomonas cepacia in the hospital setting: lack of transmission between cystic fibrosis patients. J Pediatr (1986) 1.33

Cloning of a DNA fragment encoding a heme-repressible hemoglobin-binding outer membrane protein from Haemophilus influenzae. Infect Immun (1996) 1.30

hgpB, a gene encoding a second Haemophilus influenzae hemoglobin- and hemoglobin-haptoglobin-binding protein. Infect Immun (1998) 1.26

Expression of the Haemophilus influenzae transferrin receptor is repressible by hemin but not elemental iron alone. Infect Immun (1993) 1.23

Identification of members of the Burkholderia cepacia complex by species-specific PCR. J Clin Microbiol (2000) 1.21

Binding of human hemoglobin by Haemophilus influenzae. FEMS Microbiol Lett (1994) 1.20

Recovery of Pseudomonas cepacia and other Pseudomonas species from the environment. Infect Control Hosp Epidemiol (1995) 1.16

Sneakers as a source of Pseudomonas aeruginosa in children with osteomyelitis following puncture wounds. J Pediatr (1985) 1.16

Speciation despite globally overlapping distributions in Penicillium chrysogenum: the population genetics of Alexander Fleming's lucky fungus. Mol Ecol (2011) 1.15

Pyogenic arthritis in infants and children: a review of 95 cases. Pediatr Infect Dis (1987) 1.13

Controversies affecting the future practice of clinical microbiology. J Clin Microbiol (1999) 1.11

An outbreak of Burkholderia cepacia lower respiratory tract infection associated with contaminated albuterol nebulization solution. Infect Control Hosp Epidemiol (1996) 1.11

Peritonitis involving Capnocytophaga ochracea. Diagn Microbiol Infect Dis (1985) 1.10

Comparison of susceptibility test methods to detect penicillin-resistant Streptococcus pneumoniae. Diagn Microbiol Infect Dis (1993) 1.09

A comparison of techniques for isolation of the outer membrane proteins of Haemophilus influenzae type b. Anal Biochem (1985) 1.08

Characterization of PCR-ribotyping for Burkholderia (Pseudomonas) cepacia. J Clin Microbiol (1994) 1.07

Predictors of infectious complications after burn injuries in children. Pediatr Infect Dis J (2000) 1.06

A novel tetracycline-resistant determinant, tet(U), is encoded on the plasmid pKq10 in Enterococcus faecium. Plasmid (1996) 1.06

Emergence of isolates resistant to ampicillin. Am J Dis Child (1989) 1.03

Role of CCAA nucleotide repeats in regulation of hemoglobin and hemoglobin-haptoglobin binding protein genes of Haemophilus influenzae. J Bacteriol (1999) 1.02

Pseudomonas maltophilia bacteremia in children undergoing open heart surgery. JAMA (1981) 1.02

A novel approach to insertional mutagenesis of Haemophilus influenzae. J Bacteriol (1991) 1.01

Emergence of amphibian chytridiomycosis in Britain. Vet Rec (2005) 1.01

Pathogenic factors of Pseudomonas cepacia isolates from patients with cystic fibrosis. J Med Microbiol (1990) 1.00

A role for complement receptor-like molecules in iron acquisition by Candida albicans. J Exp Med (1992) 1.00

Antimicrobial susceptibility of clinical isolates of Brucella. Diagn Microbiol Infect Dis (1986) 0.99

Human serum bactericidal activity against Haemophilus influenzae type b. J Gen Microbiol (1984) 0.99

Ribosomal RNA gene (rrn) organization in enterococci. FEMS Microbiol Lett (1994) 0.98

Characterization of hgpA, a gene encoding a haemoglobin/haemoglobin-haptoglobin-binding protein of Haemophilus influenzae. Microbiology (1999) 0.97

Source of Pseudomonas cepacia: ribotyping of isolates from patients and from the environment. J Pediatr (1993) 0.97

Haemocin, the bacteriocin produced by Haemophilus influenzae: species distribution and role in colonization. Infect Immun (1990) 0.94

Clostridium difficile cytotoxin in a pediatric population. Am J Dis Child (1983) 0.93

Bacteremia due to Bacteroides fragilis after elective appendectomy in renal transplant recipients. J Infect Dis (1981) 0.92

Two case reports and review of vascular catheter-associated bacteremia caused by nontuberculous Mycobacterium species. Pediatr Infect Dis J (1996) 0.92

Non-invasive sampling methods for the detection of Batrachochytrium dendrobatidis in archived amphibians. Dis Aquat Organ (2009) 0.92

Burkholderia cepacia in cystic fibrosis. N Engl J Med (1995) 0.90

Polyclonal anti-group B Streptococcus latex antigen detection test. Pediatr Infect Dis J (1989) 0.90

The effects of macrolides on the expression of bacterial virulence mechanisms. J Antimicrob Chemother (1998) 0.90

Transcription of genes encoding iron and heme acquisition proteins of Haemophilus influenzae during acute otitis media. Infect Immun (1997) 0.90

Piperacillin pharmacokinetics in pediatric patients. Antimicrob Agents Chemother (1982) 0.89

Human antibody response to outer membrane proteins and fimbriae of Haemophilus influenzae type b. Can J Microbiol (1988) 0.89

Potentiation of IL-1-induced BALB/3T3 fibroblast proliferation by neuropeptides. J Immunol (1988) 0.88

The growth and survivability of Streptococcus pneumoniae clinical isolates subjected to various environmental conditions. Diagn Microbiol Infect Dis (2003) 0.88

The COX-2 inhibitor market withdrawals and prescribing patterns by rheumatologists in patients with gastrointestinal and cardiovascular risk. Clin Exp Rheumatol (2009) 0.88

Nosocomial infections in the neonatal intensive care unit. Curr Opin Infect Dis (2001) 0.88

The effects of environmental conditions on the in vitro activity of selected antimicrobial agents against Escherichia coli. Curr Microbiol (1998) 0.87

Possible association of intussusception with rotavirus vaccination. American Academy of Pediatrics. Committee on Infectious Diseases. Pediatrics (1999) 0.86

Taxonomic and diagnostic markers for identification of Coccidioides immitis and Coccidioides posadasii. Med Mycol (2007) 0.86

Molecular epidemiology by ribotyping and PCR-ribotyping of Enterococcus faecium strains isolated from intercontinental areas. New Microbiol (1998) 0.85

The bactericidal activity of ampicillin, daptomycin, and vancomycin against ampicillin-resistant Enterococcus faecium. Diagn Microbiol Infect Dis (1991) 0.85

Mycobacterium fortuitum peritonitis in a patient undergoing chronic peritoneal dialysis. Diagn Microbiol Infect Dis (1986) 0.85

Identification of clinical yeast isolates by using the Microring YT. J Clin Microbiol (1993) 0.85

Distribution of a family of Haemophilus influenzae genes containing CCAA nucleotide repeating units. FEMS Microbiol Lett (1999) 0.83

Post-varicella streptococcal pyomyositis. Pediatr Infect Dis J (1989) 0.82

Continuous-infusion quinidine gluconate for treating children with severe Plasmodium falciparum malaria. J Infect Dis (1987) 0.81

Comparison of five different susceptibility test methods for detecting antimicrobial agent resistance among Haemophilus influenzae isolates. Diagn Microbiol Infect Dis (1996) 0.81

Quantitative skin cultures at potential catheter sites in neonates. Infect Control Hosp Epidemiol (1994) 0.80